Clinical trials explained: Why health literacy matters…
January 25, 2024 | Plain Language, clinical trials, design, health literacy
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take part in a clinical trial.
Most people don’t make important decisions on a whim. They tend to consider the information, weighing up the pros and cons before making a choice.
This is why there is sometimes a barrier to people agreeing to join a clinical trial; they don’t fully understand what is required of them, and not having easy access to all information can mean decision making is difficult. But there are ways in which we can support them to make an informed choice about whether to take part in a clinical trial.
This is where health literacy plays a vital role. It helps ensure that patients understand the information they have been given — by communicating complex language plainly and simply — and empowers them to make decisions about their own healthcare.
Health literacy is not just about plain language, though. Simple visuals play an important role in improving health literacy when used correctly, and they can be particularly useful for people with reading difficulties.
At Cuttsy+Cuttsy, we want clinical trial materials to be accessible to everyone. Here are some of the things we always keep in mind to ensure that everything we create is health literate and fit for purpose.
| What we do | Why we do it |
|---|---|
| Immerse ourselves in the patient’s trial journey. | To make an informed decision, patients need to know exactly what participating in the clinical trial involve, Standing in the patients’ shoes helps us to understand what information they need in order to make a choice. |
| Transform complex science into plain language and avoid using highly technical or medical terms. | Healthcare is full of confusing jargon and acronym. So, we keep it simple to ensure that patients understand what they are being asked to do. |
| Use an appropriate tone of voice. | Speaking to patients in language they would use promotes understanding and helps alleviate any fears they may have. |
| Break information down into manageable chunks. | Keeping it short and simple prevents patients being overloaded with information. |
| Use an appropriate reading age. | Following diagnosis, a patient’s reading age and comprehension can be affected. We ensure that information is simplified to support understanding. |
| Developing engaging graphics. | Graphics and images help to clarify text, give words context, and make information more appealing. |
| Create visual cues and simple iconography. | Positioning of visual cues and icons helps signpost important ‘need to knows’ whilst their consistency and familiarity can help develop trust in a study. |
| Create a story flow. | By following a logical order, content can be read more easily, and the most important informatio is more likely to be retained. |
| Use design thinking to create approachable materials with clear layouts and readability. | By focusing on the needs of patients first, we can design materials that helps to make information more accessible and less overwhelming. |
The health literacy principles that we carry through all our clinical trial work help to make information more accessible and less overwhelming for people. We know that it can be a difficult time for patients, but understanding what their participation in a clinical trial involves and truly feeling comfortable with the information they receive can also help them to retain a sense of control.
So, if you’d like to know more about how health literacy principles can improve the patient experience in your clinical trial work, let’s talk.
You can read all our latest clinical trials explained blogs here.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.
Cuttsy+Cuttsy welcomes three new experts to the team
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.
The gap between hype and reality, what patients really say about weight loss drugs
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.
Why patient-centricity depends on site-centricity in clinical trials
Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.
From cloudy to clear: visualising complex data privacy information
Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.
The invisible influence on trial retention: why caregivers must be part of the plan
Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.
Where it all began: why we wrote ‘The Site Factor’
Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.
From text to context: Helping patients see side effects clearly
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.